The culturally adapted cognitive behavioral stress management program for enhancing psychological well-being and self-management of postoperative breast cancer patients: A randomized controlled study protocol in China

一项针对中国乳腺癌术后患者,旨在提升其心理健康和自我管理能力的文化适应性认知行为压力管理方案:一项随机对照研究方案。

阅读:1

Abstract

INTRODUCTION: Breast cancer patients often face mental health challenges after prolonged treatment. High incidence and mortality rates, coupled with a shortage of healthcare professionals and heavy clinical workloads, frequently lead to the neglect of psychological care. Developing a targeted and effective psychological intervention for breast cancer patients is therefore crucial. This study aims to evaluate the efficacy of a culturally adapted cognitive behavioral stress management (CBSM) program on postoperative psychological well-being, disease-related symptoms, and self-management among breast cancer patients in China. METHODS AND ANALYSIS: A total of 72 postoperative breast cancer participants will be randomly assigned to either the intervention group or the control group. This study adopts a randomized controlled design with repeated post-test measurements. Key outcome variables, including benefit finding (primary outcome), social support, perceived stress, self-management, and quality of life (secondary outcomes), will be assessed at four time points: baseline, 1 month, 3 months, and 6 months after the intervention. DISCUSSION: This study provides a structured psychological intervention tailored to postoperative breast cancer patients in China, offering a theoretical basis for clinical psychological care in oncology settings. The findings are expected to clarify the role of the culturally adapted CBSM program in enhancing benefit finding, improving social support and self-management, and alleviating stress while boosting quality of life. By testing the adapted CBSM in the Chinese cultural context, with implications for refining cross-cultural psychological support strategies for breast cancer patients. TRIAL REGISTRATION: Chinese Clinical Trial Registry: ChiCTR2500101510; registration date: April 25, 2025.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。